The Valley Desk

Clinical trial reportCirculation. Arrhythmia and electrophysiologyPublished

Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Lankenau Institute for Medical Research, with Main Line Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Circulation. Arrhythmia and electrophysiology
Published
Subject terms
Humans; Atrial Fibrillation; Benzoates; Treatment Outcome; Double-Blind Method; Aged; Female; Male; Nasal Sprays; Heart rate; Atrial fibrillation; ECG
PubMed ID
37950726
PubMed Central ID
PMC10734780
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal